Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin 53226
17 studies enrolling now · 68 studies all time
What they study most
Acute Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Adenocarcinoma - Gastroesophageal Junction (GEJ), Adenocarcinoma Esophagus, Adenocarcinoma of Lung, Adenocarcinoma of the Stomach, Adenovirus Infection, Advanced Breast Cancer, Advanced Renal Cell Carcinoma, Advanced Solid Tumors, Allogeneic Hematopoietic Stem Cell Transplantation
Studies at this site
- Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors — Recruiting now
- A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers — Recruiting now
- Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors — Recruiting now
- Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU — Recruiting now
- A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer — Recruiting now
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) — Recruiting now
- A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer — Recruiting now
- DALY II USA/ MB-CART2019.1 for DLBCL — Recruiting now
- Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma — Recruiting now
- A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 ) — Recruiting now
- A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) — Recruiting now
- US Zamto-cel Autoimmune Diseases — Recruiting now
- A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy — Recruiting now
- Determining Individualized Cancer Therapy in Pancreatic Cancer — Recruiting now
- Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas — Recruiting now
- Platform Clinical Study for Conquering Scleroderma — Recruiting now
- Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) — Recruiting now
- Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer — Recruiting now
- MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy) — Recruiting now
- A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion). — Completed
- Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A — Running, not enrolling
- A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors — Stopped early
- A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment — Completed
- ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) — Running, not enrolling
- Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia — Completed
- Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN) — Running, not enrolling
- MRI-Based Preoperative Accelerated Partial Breast Irradiation — Running, not enrolling
- GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease — Stopped early
- Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease — Completed
- CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma — Completed
- A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer — Stopped early
- NM32-2668 in Adult Patients With Selected Advanced Solid Tumors — Stopped early
- Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma — Withdrawn before enrolling
- Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3) — Completed
- L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer — Stopped early
- Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia — Stopped early
- Antitumor-B KAC PK Study — Withdrawn before enrolling
- Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer — Completed
- Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers — Running, not enrolling
- Effect of Sleep Quality on Hematopoietic Cell Transplant Patient Outcomes — Stopped early
- Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD) — Completed
- Smartphone Pain App for Assessing Oral Mucositis Pain in Patients — Stopped early
- Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant — Stopped early
- Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia — Stopped early
- Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant — Stopped early
- Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) — Stopped early
- Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma — Stopped early
- Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) — Stopped early
- Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation — Completed
- Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation — Completed